https://www.live-feeds.com/feed/novo-nordisk-rebrands-to-novo-unveils-corporate-changes-as-it-fights-for-obesity-market-shareContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/novo-nordisk-rebrands-to-novo-unveils-corporate-changes-as-it-fights-for-obesity-market-sharehttps://www.live-feeds.com/feed/novo-nordisk-rebrands-to-novo-unveils-corporate-changes-as-it-fights-for-obesity-market-share#u70148Wed, 16 Sep 2026 10:10:31 +0000Drugmaker Novo Nordisk has shortened its identity to Novo while introducing a new culture framework. This strategic reset aims to sharpen competitiveness in the anti-obesity sector as the maker of Ozempic and Wegovy battles fierce rivalry. The corporate overhaul comes in response to falling market share, a leadership change, and a drop in share price while facing intensifying pressure from competitor Eli Lilly. The shift is designed to make the company more memorable and restore momentum rather than act as a financial restructuring.Why it mattersThe pharmaceutical company is trying to recaptur https://www.live-feeds.com/feed/novo-nordisk-rebrands-to-novo-unveils-corporate-changes-as-it-fights-for-obesity-market-sharehttps://www.live-feeds.com/feed/novo-nordisk-rebrands-to-novo-unveils-corporate-changes-as-it-fights-for-obesity-market-share#u68987Tue, 15 Sep 2026 12:37:47 +0000Drugmaker Novo Nordisk has dropped Nordisk from its name, rebranding simply as Novo to boost recognition in the competitive obesity market. The Danish pharmaceutical company also unveiled a new slogan and a set of cultural principles. The corporate overhaul comes as the company trails competitor Eli Lilly in the obesity drug sector. The rebrand arrives during a challenging period for the company, marked by falling market share, a leadership change, and a drop in share price.Why it mattersThe corporate shift reflects intense competition in the booming market for weight-loss treatments. Novo fac